跳至主要内容
临床试验/NCT05691179
NCT05691179招募中不适用

The Association of COVID-19 Infection and Relapse of Idiopathic Membranous Nephropathy

Beijing Friendship Hospital3 个研究点 分布在 1 个国家目标入组 130 人开始时间: 2022年12月10日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
130
试验地点
3
主要终点
primary outcome

研究概览

简要总结

Infection is one of common risk factors for relapsing of idiopathic membranous nephropathy (IMN). However, it is still unclear wheather COVID-19 infection can induce the relapsing of IMN. Herein, in this prospective, multi-center, cohort study, the investigator enrolled the IMN patients with COVID-19 infection.

All subjects will be followed for three months with four visits at 1, 2 and 3 months. Then the investigator will compare the rate of replase of IMN in the two groups to evaluate the association of COVID-19 infection and replapse of IMN.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • the status of nephrotic syndrome is complete remmision or partial remmision;
  • estimated glomerular filtration rate (eGFR according to the CKD-EPI formula) ≥60 mL/min per 1.73 m2;
  • patients with a moderate risk of IMN.

排除标准

  • secondary causes of MN;
  • the labarotary data two months before enrolement is absent.

结局指标

主要结局

primary outcome

时间窗: 3 months

relaspe of nephrotic syndrome: proteinuria\<0.3g/d, serum albumin\>30g/l, serum creatitine below 111 μmol/l

次要结局

  • secondary outcome(0.5, 1, and 2 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Wenhu Liu

Professor Wenhu Liu

Beijing Friendship Hospital

研究点 (3)

Loading locations...

相似试验